SSE Ticker: 688016

Shanghai Microport Endovascular Medtech Co., Ltd.

心脉医疗

Authorized Representative: 彭博

Board: Star Market

Industry Classification: Biomedicine

Hexun SGI Index 2021 Annual Report TOP30 List Released! The top three on the list have changed a lot. Baichu Electronics won the top spot, while Montage Technology and others fell off the list.

Post date May 16, 2022 — 10:01 Post Lock

Hexun SGI Index 2021 Annual Report TOP30 List Released! The top three on the list have changed a lot. Bochu Electronics won the top spot, while Montage Technology and others fell on the list.

Post date May 16, 2022 — 10:00 Post Lock

The average share price of the Science and Technology Innovation Board is 30.40 yuan, and the share price of 8 shares exceeds 300 yuan_Oriental Fortune Net

Post date May 10, 2022 — 18:53 Post Lock

The average share price of the Science and Technology Innovation Board is 30.40 yuan, and the share price of 8 shares exceeds 300 yuan.

Post date May 10, 2022 — 18:53 Post Lock

Zheshang Securities: Give Xinmai Medical an overweight rating, with a target price of 234.61 yuan_Stock News_Market Gold Online

Post date May 7, 2022 — 12:38 Post Lock

Zheshang Securities assigns an overweight rating to Cardiovascular Medical: the leader in vascular intervention has high growth or continued – yqqlm

Post date May 7, 2022 — 12:11 Post Lock

Zheshang Securities gives Cardiovascular Medical an overweight rating: leading vascular intervention, high growth or continuous

Post date May 7, 2022 — 12:02 Post Lock

Zhongtai Securities gave Xinmai Medical a buy rating, maintaining rapid growth under the impact of the epidemic, and a number of innovative products are expected to open clinical trials within this year.

Post date May 6, 2022 — 11:38 Post Lock

Shanghai Stock Connect added 21 stocks on the Science and Technology Innovation Board yesterday_ Oriental Fortune Net

Post date May 6, 2022 — 10:20 Post Lock

Summary of the 2021 annual report and 2022 first quarter report of the medical sector of Sinolink Securities: The overall performance is clear, and it still maintains a strong growth ability! -Funds Financial Sector

Post date May 5, 2022 — 16:30 Post Lock

Xinmai Medical disclosed that it achieved revenue of 258 million yuan in the first quarter of 2022 – yqqlm

Post date May 5, 2022 — 11:09 Post Lock

The boom is still high! The 2021 annual report of CSI Medical ended perfectly, and the performance of the top ten stocks increased by 48%! 1st Quarterly Report Gao Liang Continues-Funds-Finance

Post date April 29, 2022 — 18:55 Post Lock

The 100 yuan shares of the Science and Technology Innovation Board reached 55 Hemai shares with the highest share price_Oriental Fortune Net

Post date April 29, 2022 — 18:42 Post Lock

The boom is still high! The 2021 annual report of CSI Medical ended perfectly, and the performance of the top ten stocks increased by 48%! The first quarterly report Gao Liang continues-

Post date April 29, 2022 — 16:55 Post Lock

31 Sci-tech Innovation Board stocks received northbound funds to increase their positions_Oriental Fortune Network

Post date April 28, 2022 — 11:28 Post Lock

The performance is still high! The 2021 annual report profits of 44 CSI Medical shares increased by 32%! 1st Quarterly Report Gao Liang Continues-Funds-Finance

Post date April 28, 2022 — 11:27 Post Lock

Ranking of high-priced stocks on the Science and Technology Innovation Board

Post date April 26, 2022 — 19:01 Post Lock

The sector has fallen one after another, and new shares have broken out. How to invest in pharmaceutical and biological stocks in the second quarter? -Stock Channel-Hexun.com

Post date April 23, 2022 — 11:20 Post Lock

The market is sluggish again, and the performance is still booming! China Securities Medical has disclosed 33 shares with a total net profit of 45.2 billion yuan, a year-on-year increase of 46%! -Funds Financial Sector

Post date April 21, 2022 — 13:51 Post Lock

The market is hesitant, but the performance is still high! China Securities Medical has disclosed 29 shares with a total net profit of 34.25 billion yuan, a year-on-year increase of 54%! -Funds Financial Sector

Post date April 19, 2022 — 15:30 Post Lock

Want to see more data? Registered subscribers can see all the data.